Stocks / NASDAQ / Ironwood Pharmaceuticals, Inc.

Ironwood Pharmaceuticals, Inc.

Industry:   Health Care - Major Pharmaceuticals Stock Symbol:   IRWD - NASDAQ Animal Usage:   Animal Testing

Our Opinion

Ironwood Pharmaceuticals, Inc. is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of their medical analysis and clinical research.

Supporting Evidence:

The company stated in the following press release that they conduct pre-clinical trials of their drugs on animals.

“Through its action at GC-C, linaclotide has been shown to reduce visceral pain and increase GI transit in animal models and increase colonic transit in humans. ” Read the following article

Company Description

Ironwood Pharmaceuticals, Inc. is a pharmaceutical company. It discovers, develops and intends to commercialize differentiated medicines that improve patient’s lives. Its products include linaclotide, a guanylate cyclase type-C agonist being developed for the treatment of patients with irritable bowel syndrome with constipation and chronic constipation. The company was founded by Peter M. Hecht, Eric F. Summers, G. Todd Milne, Brian M. Cali, Joseph C. Cook, Jr. and Gina Bornino Miller on January 5, 1998 and is headquartered in Cambridge, MA. [Source: MarketWatch]

Company Website: https://www.ironwoodpharma.com

Contact:   https://www.ironwoodpharma.com/contact-us; IR: mkaya@ironwoodpharma.com;